JPS6442430A - Side effect remover for chemotherapeutic agent - Google Patents
Side effect remover for chemotherapeutic agentInfo
- Publication number
- JPS6442430A JPS6442430A JP62200365A JP20036587A JPS6442430A JP S6442430 A JPS6442430 A JP S6442430A JP 62200365 A JP62200365 A JP 62200365A JP 20036587 A JP20036587 A JP 20036587A JP S6442430 A JPS6442430 A JP S6442430A
- Authority
- JP
- Japan
- Prior art keywords
- carnosine
- remover
- chemotherapeutic agents
- side effect
- biosynthesis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002246 antineoplastic agent Substances 0.000 title abstract 4
- 229940127089 cytotoxic agent Drugs 0.000 title abstract 4
- 230000000694 effects Effects 0.000 title abstract 4
- 108010087806 Carnosine Proteins 0.000 abstract 4
- CQOVPNPJLQNMDC-UHFFFAOYSA-N N-beta-alanyl-L-histidine Natural products NCCC(=O)NC(C(O)=O)CC1=CN=CN1 CQOVPNPJLQNMDC-UHFFFAOYSA-N 0.000 abstract 4
- CQOVPNPJLQNMDC-ZETCQYMHSA-N carnosine Chemical compound [NH3+]CCC(=O)N[C@H](C([O-])=O)CC1=CNC=N1 CQOVPNPJLQNMDC-ZETCQYMHSA-N 0.000 abstract 4
- 239000004480 active ingredient Substances 0.000 abstract 2
- 230000015572 biosynthetic process Effects 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 2
- 229940079593 drug Drugs 0.000 abstract 2
- 230000002401 inhibitory effect Effects 0.000 abstract 2
- 238000002347 injection Methods 0.000 abstract 2
- 239000007924 injection Substances 0.000 abstract 2
- 150000007523 nucleic acids Chemical class 0.000 abstract 2
- 102000039446 nucleic acids Human genes 0.000 abstract 2
- 108020004707 nucleic acids Proteins 0.000 abstract 2
- 239000000843 powder Substances 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 239000000126 substance Substances 0.000 abstract 2
- 241000725303 Human immunodeficiency virus Species 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 239000002775 capsule Substances 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 238000007796 conventional method Methods 0.000 abstract 1
- 235000013305 food Nutrition 0.000 abstract 1
- 239000008187 granular material Substances 0.000 abstract 1
- 201000002364 leukopenia Diseases 0.000 abstract 1
- 231100001022 leukopenia Toxicity 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000003826 tablet Substances 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP62200365A JPS6442430A (en) | 1987-08-11 | 1987-08-11 | Side effect remover for chemotherapeutic agent |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP62200365A JPS6442430A (en) | 1987-08-11 | 1987-08-11 | Side effect remover for chemotherapeutic agent |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS6442430A true JPS6442430A (en) | 1989-02-14 |
| JPH0513928B2 JPH0513928B2 (en, 2012) | 1993-02-23 |
Family
ID=16423091
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP62200365A Granted JPS6442430A (en) | 1987-08-11 | 1987-08-11 | Side effect remover for chemotherapeutic agent |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS6442430A (en, 2012) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0881371A (ja) * | 1994-09-09 | 1996-03-26 | Suntory Ltd | 造血機能亢進剤 |
| JP2005532269A (ja) * | 2002-02-28 | 2005-10-27 | ヴラディミール エフゲニエヴィッチ ネボルシン | 細胞分化の誘発方法 |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR960010020A (ko) | 1994-09-09 | 1996-04-20 | 도리이 신이치로 | 조혈 기능 항진제 |
-
1987
- 1987-08-11 JP JP62200365A patent/JPS6442430A/ja active Granted
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0881371A (ja) * | 1994-09-09 | 1996-03-26 | Suntory Ltd | 造血機能亢進剤 |
| JP2005532269A (ja) * | 2002-02-28 | 2005-10-27 | ヴラディミール エフゲニエヴィッチ ネボルシン | 細胞分化の誘発方法 |
| US7759313B2 (en) | 2002-02-28 | 2010-07-20 | Obschetstvo S Ogranichennoi Otvetstvennostiyu “Pharmenterprises” | Induction method for cell differentiation |
| EP1491206B1 (en) * | 2002-02-28 | 2010-11-17 | Obschestvo S Ogranichennoi Otvetstennostiyu "Pharmenterprises" | Use of peptide derivatives for inducing cell differentiation |
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0513928B2 (en, 2012) | 1993-02-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR950013753B1 (ko) | 분무 건조된 아세트아미노펜, 이의 제조방법 및 이를 함유하는 약제학적 제형 | |
| HUT51254A (en) | Process for producing amino acid derivatives and pharmaceutical compositions comprising same as active ingredient | |
| NZ229518A (en) | Pharmaceutical dosage form for the medication of fish: method of administration and (prophylactic) treatment | |
| IE791806L (en) | Gastroprotective mollusc extract | |
| RU95101385A (ru) | Продукты, содержащие g-csf и tnf связующие протеина | |
| JPS56104815A (en) | Remedy for peripheral orthostatic hypotension | |
| Brunner et al. | Comparison of the Biologic Activity of VP-16-213 Given Iv and Orally in Capsules or Drink Ampules 1, 2 | |
| IE894050L (en) | Compound with gastric acid inhibitory effect and process for¹its preparation | |
| HUT50334A (en) | Process for producing arylpiperazinyl-alkilenephenyl-p-heterocycluc compounds, pharmaceutically acceptable acid addition salts thereof and pharmaceutical compositions comprising the compounds as active ingredient | |
| JPS6442430A (en) | Side effect remover for chemotherapeutic agent | |
| CA1334166C (en) | Antiviral preparation containing dideoxy-nucleosides | |
| EP0271151A3 (en) | Azumolene dosage form | |
| KR860006265A (ko) | 9,10-디하이드로 에르고트 알카로이드를 함유하는 서방성 제재의 제조방법 | |
| JPH07118148A (ja) | 肝癌予防剤 | |
| JP2000204037A (ja) | 筋萎縮性側索硬化症治療薬 | |
| CA2093258A1 (en) | Cytarabine ocfosfate hard capsule | |
| EP0253697A3 (fr) | Médicament et composition médicamenteuse pour le traitement de maladies infectieuses dues aux virus, ainsi que pour le traitement des tumeurs | |
| Silvasti et al. | Pharmacokinetic comparison of a dextromethorphan-salbutamol combination tablet and a plain dextromethorphan tablet | |
| JPH0769877A (ja) | 分枝鎖アミノ酸を有効成分とする経口投与薬 | |
| Hladovec et al. | Oral contraceptives, methionine and endothelial lesion | |
| JP2000229853A (ja) | 生理痛改善用組成物 | |
| HUT53121A (en) | Process for producing amino acid derivatives and pharmaceutical compositions comprising such compounds as active ingredient | |
| JPS5462327A (en) | Remedy for dna virus infectious disease | |
| EP0367509A3 (en) | Formulations | |
| Al-Achi et al. | Buccal administration of erythrocyte-ghosts-insulin in rats |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| LAPS | Cancellation because of no payment of annual fees |